These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 509217)

  • 1. Pharmacological characterization of adrenal paraneurons: substance P and somatostatin as inhibitory modulators of the nicotinic response.
    Mizobe F; Kozousek V; Dean DM; Livett BG
    Brain Res; 1979 Dec; 178(2-3):555-66. PubMed ID: 509217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receptors and receptor modulation in cultured chromaffin cells.
    Livett BG; Boksa P
    Can J Physiol Pharmacol; 1984 Apr; 62(4):467-76. PubMed ID: 6203633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Further evidence for nicotinic and muscarinic receptors and their interaction in dog adrenal medulla.
    Tsujimoto A; Nishikawa T
    Eur J Pharmacol; 1975 Dec; 34(2):337-44. PubMed ID: 1234552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-term exposure to somatostatin or muscarinic agonists reduce acetylcholine-induced 3H-MPP+ release from bovine adrenal medullary cells.
    Ribeiro L; Martel F; Azevedo I
    J Biomed Sci; 2007 May; 14(3):347-55. PubMed ID: 17225960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nicotinic and muscarinic components in acetylcholine stimulation of porcine adrenal medullary cells.
    Nassar-Gentina V; Catalán L; Luxoro M
    Mol Cell Biochem; 1997 Apr; 169(1-2):107-13. PubMed ID: 9089637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological activity of N-methyl-carbamylcholine, a novel acetylcholine receptor agonist with selectivity for nicotinic receptors.
    Boksa P; Quik M; Mitchell JB; Collier B; O'Neil W; Quirion R
    Eur J Pharmacol; 1989 Nov; 173(1):93-108. PubMed ID: 2606158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substance P protects against desensitization of the nicotinic response in isolated adrenal chromaffin cells.
    Boksa P; Livett BG
    J Neurochem; 1984 Mar; 42(3):618-27. PubMed ID: 6198467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of the differential effects of halothane on nicotinic- and muscarinic-receptor-mediated responses of the dog adrenal medulla.
    Sumikawa K; Matsumoto T; Ishizaka N; Nagai H; Amenomori Y; Amakata Y
    Anesthesiology; 1982 Dec; 57(6):444-50. PubMed ID: 7149302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Release of [3H]-noradrenaline from rat hippocampal synaptosomes by nicotine: mediation by different nicotinic receptor subtypes from striatal [3H]-dopamine release.
    Clarke PB; Reuben M
    Br J Pharmacol; 1996 Feb; 117(4):595-606. PubMed ID: 8646402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The release of 3H-1-methyl-4-phenylpyridinium from bovine adrenal chromaffin cells is modulated by somatostatin.
    Ribeiro L; Martel F; Azevedo I
    Regul Pept; 2006 Dec; 137(3):107-13. PubMed ID: 16846655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substance P modulates the time course of nicotinic but not muscarinic catecholamine secretion from perfused adrenal glands of rat.
    Zhou XF; Marley PD; Livett BG
    Br J Pharmacol; 1991 Sep; 104(1):159-65. PubMed ID: 1723914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A patch clamp study of the nicotinic acetylcholine receptor of bovine adrenomedullary chromaffin cells in culture.
    Nooney JM; Peters JA; Lambert JJ
    J Physiol; 1992 Sep; 455():503-27. PubMed ID: 1282932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nicotinic autoreceptors mediating enhancement of acetylcholine release become operative in conditions of "impaired" cholinergic presynaptic function.
    Marchi M; Raiteri M
    J Neurochem; 1996 Nov; 67(5):1974-81. PubMed ID: 8863503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ouabain distinguishes between nicotinic and muscarinic receptor-mediated catecholamine secretions in perfused adrenal glands of cat.
    Yamada Y; Nakazato Y; Ohga A
    Br J Pharmacol; 1989 Feb; 96(2):470-9. PubMed ID: 2924087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Voltage-independent catecholamine release mediated by the activation of muscarinic receptors in guinea-pig adrenal glands.
    Nakazato Y; Ohga A; Oleshansky M; Tomita U; Yamada Y
    Br J Pharmacol; 1988 Jan; 93(1):101-9. PubMed ID: 3349226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological dissection of receptor-associated and voltage-sensitive ionic channels involved in catecholamine release.
    Ceña V; Nicolas GP; Sanchez-Garcia P; Kirpekar SM; Garcia AG
    Neuroscience; 1983 Dec; 10(4):1455-62. PubMed ID: 6320053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of lobeline on catecholamine release from the isolated perfused rat adrenal gland.
    Lim DY; Kim YS; Miwa S
    Auton Neurosci; 2004 Jan; 110(1):27-35. PubMed ID: 14766322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholinesterase activity and exposure time to acetylcholine as factors influencing the muscarinic inhibition of [3H]-noradrenaline overflow from guinea-pig isolated atria.
    Fuder H; Muscholl E; Wolf K
    Br J Pharmacol; 1985 Dec; 86(4):905-14. PubMed ID: 2866805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of isolated chromaffin cells to study basic release mechanisms.
    Livett BG; Boksa P; Dean DM; Mizobe F; Lindenbaum MH
    J Auton Nerv Syst; 1983 Jan; 7(1):59-86. PubMed ID: 6188774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholinergic receptors and catecholamine secretion from adrenal chromaffin cells of the toad.
    Nassar-Gentina V; Luxoro M; Urbina N
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1991; 100(3):495-500. PubMed ID: 1687546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.